Single-Dose AAV-bNAb Gene Therapy at Birth Holds Potential for Prolonged HIV-1 Immunity
Single-dose gene therapy at birth protected macaques from HIV
into adolescence, offering hope for pediatric prevention. |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.